Searched for
HETERO LABS
Optimus too could launch Covid pill Paxlovid soonThe company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator ...26 Apr, 2022, 12.51 AM IST- Pfizer's "game-changing" COVID-19 pill, Paxlovid, gets DCGI nodPfizer had last year announced a deal with MPP, a UN-backed body, to issue royalty-free voluntary licences to manufacture generic versions ...23 Apr, 2022, 07.43 AM IST
- Nod for Paxlovid's Indian generic version to take longerHetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. Howeve...19 Feb, 2022, 12.39 AM IST
- Panel seeks extra data on Merck's Covid drugThe SEC of the Central Drugs Standard Control Organisation (CDSCO) on Monday reviewed applications from Dr Reddy's, Hetero Labs, Natco Phar...07 Dec, 2021, 03.53 PM IST
- Hetero gets DGCI approval for generic version of tocilizumab for treatment of Covid-19"The Drug Controller General of India (DCGI) has issued for restricted use, Emergency Use Authorisation (EUA) for the generic version of To...06 Sep, 2021, 12.47 PM IST
- MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...27 Apr, 2021, 04.09 PM IST
- Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patientGilead has tied up with generic drugmakers based in India and Pakistan, including Cipla Ltd and Hetero Labs Ltd, to make and supply remdesi...29 Jun, 2020, 11.10 PM IST
- Cipla to price remdesivir version for COVID-19 under 5,000 rupeesIndian pharma major Cipla Ltd and Hetero Labs gained approval to sell generic versions of remdesivir in the country. Remdesivir, intravenou...23 Jun, 2020, 05.29 PM IST
- Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell RemdesivirCipla, Hetero, and Jubilant Lifesciences have signed voluntary licensing agreements with Gilead.25 May, 2020, 08.22 AM IST
- Cipla and Hetero seek clinical trial waiver for RemdesivirWhile all new drugs must undergo trials before getting marketing approval in India, the regulator can grant exemptions in public interest a...23 May, 2020, 08.14 AM IST
- ‘We will ensure Remdesivir supply when India wants it’Hyderabad based generic pharmaceutical company Hetero Labs is working on a “war footing” to make remdesivir available for Covid-19 patients...14 May, 2020, 07.23 AM IST
- Hetero launches HumiraTM biosimilar in IndiaThe product will be marketed by Hetero Healthcare under the brand name ‘MaburaTM’ in India, the company said.04 Jan, 2018, 06.09 AM IST
- USFDA notice to Hetero over conditions at Telangana unitThe 13-page observation by investigators Massoud Motamed and Latorie Jones noted several deviations that were against good manufacturing pr...24 Jan, 2017, 01.59 AM IST
- Post Invagen sale, Hetero says to strengthen US operationsCipla said the group, through its subsidiary Camber Pharmaceuticals Inc., will continue to strengthen its operations in the US.05 Sep, 2015, 09.58 AM IST
- Hetero Labs to produce Gilead's HIV drugs, through Medicines Patent PoolHyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...31 Jul, 2012, 04.08 PM IST
- Three cos bag Rs 92-lakh swine flu drug orderRanbaxy Labs, Hetero Drugs and Strides Acrolabs have together bagged orders to supply 92-lakh capsules of generic or low-priced version of ...02 Sep, 2009, 01.00 AM IST
- Global swine flu kit makers gear up to meet demandUS-based Applied Biosystems and Swiss firm Roche Diagnostics , have said that they are ramping up their manufacturing capacities to meet ri...14 Aug, 2009, 02.14 PM IST
Load More
